 | • レポートコード：MRC2312MG04050 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、60ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のシスプラチン化学療法市場規模と予測を収録しています。・世界のシスプラチン化学療法市場：売上、2018年-2023年、2024年-2029年 ・世界のシスプラチン化学療法市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のシスプラチン化学療法市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「50ml」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 シスプラチン化学療法のグローバル主要企業は、Pfizer、 Teva、 Cipla、 Taj Pharmaceuticals、 Qilu Pharmaceutical、 Nanjing Pharmaceutical Factory、 Fresenius Kabi、 Manus Aktteva Biopharma、 Jiangsu Hansoh Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、シスプラチン化学療法のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のシスプラチン化学療法市場：タイプ別、2018年-2023年、2024年-2029年 世界のシスプラチン化学療法市場：タイプ別市場シェア、2022年 ・50ml、100ml、200ml 世界のシスプラチン化学療法市場：用途別、2018年-2023年、2024年-2029年 世界のシスプラチン化学療法市場：用途別市場シェア、2022年 ・卵巣がん、精巣がん、その他 世界のシスプラチン化学療法市場：地域・国別、2018年-2023年、2024年-2029年 世界のシスプラチン化学療法市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるシスプラチン化学療法のグローバル売上、2018年-2023年 ・主要企業におけるシスプラチン化学療法のグローバル売上シェア、2022年 ・主要企業におけるシスプラチン化学療法のグローバル販売量、2018年-2023年 ・主要企業におけるシスプラチン化学療法のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Pfizer、 Teva、 Cipla、 Taj Pharmaceuticals、 Qilu Pharmaceutical、 Nanjing Pharmaceutical Factory、 Fresenius Kabi、 Manus Aktteva Biopharma、 Jiangsu Hansoh Pharmaceutical ************************************************************* ・調査・分析レポートの概要 シスプラチン化学療法市場の定義 市場セグメント 世界のシスプラチン化学療法市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のシスプラチン化学療法市場規模 世界のシスプラチン化学療法市場規模：2022年 VS 2029年 世界のシスプラチン化学療法市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのシスプラチン化学療法の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のシスプラチン化学療法製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：50ml、100ml、200ml シスプラチン化学療法のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：卵巣がん、精巣がん、その他 シスプラチン化学療法の用途別グローバル売上・予測 ・地域別市場分析 地域別シスプラチン化学療法市場規模 2022年と2029年 地域別シスプラチン化学療法売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Pfizer、 Teva、 Cipla、 Taj Pharmaceuticals、 Qilu Pharmaceutical、 Nanjing Pharmaceutical Factory、 Fresenius Kabi、 Manus Aktteva Biopharma、 Jiangsu Hansoh Pharmaceutical ... |
This research report provides a comprehensive analysis of the Cisplatin Chemotherapy market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cisplatin Chemotherapy market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cisplatin Chemotherapy, challenges faced by the industry, and potential opportunities for market players.
The global Cisplatin Chemotherapy market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cisplatin Chemotherapy market presents opportunities for various stakeholders, including Ovarian Cancer, Testicular Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cisplatin Chemotherapy market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cisplatin Chemotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Platinum-based drugs contain coordinated complexes of platinum. These are widely used in the treatment of cancer as chemotherapeutic agents. Platinum acts as cell damaging agent for certain cancer treatments. Approximately 10% to 20% patients treated with chemotherapy receive platinum-based drugs. These drugs are used either alone or in combination with other drug treatment. Rise in prevalence of cancer is a major driver of the global cisplatin market.
Key Features:
The research report on the Cisplatin Chemotherapy market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cisplatin Chemotherapy market.
Market Overview: The report provides a comprehensive overview of the Cisplatin Chemotherapy market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 50ml, 100ml), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cisplatin Chemotherapy market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cisplatin Chemotherapy market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cisplatin Chemotherapy market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cisplatin Chemotherapy market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cisplatin Chemotherapy market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cisplatin Chemotherapy market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cisplatin Chemotherapy, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cisplatin Chemotherapy market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cisplatin Chemotherapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
50ml
100ml
200ml
Market segment by Application
Ovarian Cancer
Testicular Cancer
Others
Global Cisplatin Chemotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Pfizer
Teva
Cipla
Taj Pharmaceuticals
Qilu Pharmaceutical
Nanjing Pharmaceutical Factory
Fresenius Kabi
Manus Aktteva Biopharma
Jiangsu Hansoh Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cisplatin Chemotherapy, market overview.
Chapter 2: Global Cisplatin Chemotherapy market size in revenue.
Chapter 3: Detailed analysis of Cisplatin Chemotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cisplatin Chemotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Cisplatin Chemotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cisplatin Chemotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cisplatin Chemotherapy Overall Market Size
2.1 Global Cisplatin Chemotherapy Market Size: 2022 VS 2029
2.2 Global Cisplatin Chemotherapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cisplatin Chemotherapy Players in Global Market
3.2 Top Global Cisplatin Chemotherapy Companies Ranked by Revenue
3.3 Global Cisplatin Chemotherapy Revenue by Companies
3.4 Top 3 and Top 5 Cisplatin Chemotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cisplatin Chemotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cisplatin Chemotherapy Players in Global Market
3.6.1 List of Global Tier 1 Cisplatin Chemotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cisplatin Chemotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Cisplatin Chemotherapy Market Size Markets, 2022 & 2029
4.1.2 50ml
4.1.3 100ml
4.1.4 200ml
4.2 By Type – Global Cisplatin Chemotherapy Revenue & Forecasts
4.2.1 By Type – Global Cisplatin Chemotherapy Revenue, 2018-2023
4.2.2 By Type – Global Cisplatin Chemotherapy Revenue, 2024-2029
4.2.3 By Type – Global Cisplatin Chemotherapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cisplatin Chemotherapy Market Size, 2022 & 2029
5.1.2 Ovarian Cancer
5.1.3 Testicular Cancer
5.1.4 Others
5.2 By Application – Global Cisplatin Chemotherapy Revenue & Forecasts
5.2.1 By Application – Global Cisplatin Chemotherapy Revenue, 2018-2023
5.2.2 By Application – Global Cisplatin Chemotherapy Revenue, 2024-2029
5.2.3 By Application – Global Cisplatin Chemotherapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Cisplatin Chemotherapy Market Size, 2022 & 2029
6.2 By Region – Global Cisplatin Chemotherapy Revenue & Forecasts
6.2.1 By Region – Global Cisplatin Chemotherapy Revenue, 2018-2023
6.2.2 By Region – Global Cisplatin Chemotherapy Revenue, 2024-2029
6.2.3 By Region – Global Cisplatin Chemotherapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Cisplatin Chemotherapy Revenue, 2018-2029
6.3.2 US Cisplatin Chemotherapy Market Size, 2018-2029
6.3.3 Canada Cisplatin Chemotherapy Market Size, 2018-2029
6.3.4 Mexico Cisplatin Chemotherapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Cisplatin Chemotherapy Revenue, 2018-2029
6.4.2 Germany Cisplatin Chemotherapy Market Size, 2018-2029
6.4.3 France Cisplatin Chemotherapy Market Size, 2018-2029
6.4.4 U.K. Cisplatin Chemotherapy Market Size, 2018-2029
6.4.5 Italy Cisplatin Chemotherapy Market Size, 2018-2029
6.4.6 Russia Cisplatin Chemotherapy Market Size, 2018-2029
6.4.7 Nordic Countries Cisplatin Chemotherapy Market Size, 2018-2029
6.4.8 Benelux Cisplatin Chemotherapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Cisplatin Chemotherapy Revenue, 2018-2029
6.5.2 China Cisplatin Chemotherapy Market Size, 2018-2029
6.5.3 Japan Cisplatin Chemotherapy Market Size, 2018-2029
6.5.4 South Korea Cisplatin Chemotherapy Market Size, 2018-2029
6.5.5 Southeast Asia Cisplatin Chemotherapy Market Size, 2018-2029
6.5.6 India Cisplatin Chemotherapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Cisplatin Chemotherapy Revenue, 2018-2029
6.6.2 Brazil Cisplatin Chemotherapy Market Size, 2018-2029
6.6.3 Argentina Cisplatin Chemotherapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Cisplatin Chemotherapy Revenue, 2018-2029
6.7.2 Turkey Cisplatin Chemotherapy Market Size, 2018-2029
6.7.3 Israel Cisplatin Chemotherapy Market Size, 2018-2029
6.7.4 Saudi Arabia Cisplatin Chemotherapy Market Size, 2018-2029
6.7.5 UAE Cisplatin Chemotherapy Market Size, 2018-2029
7 Cisplatin Chemotherapy Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Cisplatin Chemotherapy Major Product Offerings
7.1.4 Pfizer Cisplatin Chemotherapy Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Teva
7.2.1 Teva Company Summary
7.2.2 Teva Business Overview
7.2.3 Teva Cisplatin Chemotherapy Major Product Offerings
7.2.4 Teva Cisplatin Chemotherapy Revenue in Global Market (2018-2023)
7.2.5 Teva Key News & Latest Developments
7.3 Cipla
7.3.1 Cipla Company Summary
7.3.2 Cipla Business Overview
7.3.3 Cipla Cisplatin Chemotherapy Major Product Offerings
7.3.4 Cipla Cisplatin Chemotherapy Revenue in Global Market (2018-2023)
7.3.5 Cipla Key News & Latest Developments
7.4 Taj Pharmaceuticals
7.4.1 Taj Pharmaceuticals Company Summary
7.4.2 Taj Pharmaceuticals Business Overview
7.4.3 Taj Pharmaceuticals Cisplatin Chemotherapy Major Product Offerings
7.4.4 Taj Pharmaceuticals Cisplatin Chemotherapy Revenue in Global Market (2018-2023)
7.4.5 Taj Pharmaceuticals Key News & Latest Developments
7.5 Qilu Pharmaceutical
7.5.1 Qilu Pharmaceutical Company Summary
7.5.2 Qilu Pharmaceutical Business Overview
7.5.3 Qilu Pharmaceutical Cisplatin Chemotherapy Major Product Offerings
7.5.4 Qilu Pharmaceutical Cisplatin Chemotherapy Revenue in Global Market (2018-2023)
7.5.5 Qilu Pharmaceutical Key News & Latest Developments
7.6 Nanjing Pharmaceutical Factory
7.6.1 Nanjing Pharmaceutical Factory Company Summary
7.6.2 Nanjing Pharmaceutical Factory Business Overview
7.6.3 Nanjing Pharmaceutical Factory Cisplatin Chemotherapy Major Product Offerings
7.6.4 Nanjing Pharmaceutical Factory Cisplatin Chemotherapy Revenue in Global Market (2018-2023)
7.6.5 Nanjing Pharmaceutical Factory Key News & Latest Developments
7.7 Fresenius Kabi
7.7.1 Fresenius Kabi Company Summary
7.7.2 Fresenius Kabi Business Overview
7.7.3 Fresenius Kabi Cisplatin Chemotherapy Major Product Offerings
7.7.4 Fresenius Kabi Cisplatin Chemotherapy Revenue in Global Market (2018-2023)
7.7.5 Fresenius Kabi Key News & Latest Developments
7.8 Manus Aktteva Biopharma
7.8.1 Manus Aktteva Biopharma Company Summary
7.8.2 Manus Aktteva Biopharma Business Overview
7.8.3 Manus Aktteva Biopharma Cisplatin Chemotherapy Major Product Offerings
7.8.4 Manus Aktteva Biopharma Cisplatin Chemotherapy Revenue in Global Market (2018-2023)
7.8.5 Manus Aktteva Biopharma Key News & Latest Developments
7.9 Jiangsu Hansoh Pharmaceutical
7.9.1 Jiangsu Hansoh Pharmaceutical Company Summary
7.9.2 Jiangsu Hansoh Pharmaceutical Business Overview
7.9.3 Jiangsu Hansoh Pharmaceutical Cisplatin Chemotherapy Major Product Offerings
7.9.4 Jiangsu Hansoh Pharmaceutical Cisplatin Chemotherapy Revenue in Global Market (2018-2023)
7.9.5 Jiangsu Hansoh Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
